Farther Finance Advisors’s Indivior Pharmaceuticals INDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.2K Buy
444
+116
+35% +$4.21K ﹤0.01% 4043
2026
Q1
$10.1K Sell
328
-290
-47% -$9.58K ﹤0.01% 4111
2025
Q4
$22.2K Buy
618
+603
+4,020% +$18.4K ﹤0.01% 3372
2025
Q3
$362 Buy
+15
New +$314 ﹤0.01% 4615
2025
Q1
Sell
-1,840
Closed -$22.9K 4338
2024
Q4
$22.9K Hold
1,840
﹤0.01% 2028
2024
Q3
$17.9K Hold
1,840
﹤0.01% 2133
2024
Q2
$29K Hold
1,840
﹤0.01% 1635
2024
Q1
$38.7K Buy
+1,840
New +$34.6K ﹤0.01% 1269

Other funds holding INDV

Farther Finance Advisors's INDV Position: Q2 2026 in Review

Farther Finance Advisors increased its Indivior Pharmaceuticals (INDV) stake by 35% in Q2 2026, buying an estimated $4.21K and bringing the position to 444 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4043.

Farther Finance Advisors first reported a position in INDV in Q1 2024 and has held it in 8 quarters since. The position peaked at $38.7K in Q1 2024. 49 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Farther Finance Advisors held 444 shares of Indivior Pharmaceuticals worth $18.2K as of Q2 2026.
  • Farther Finance Advisors bought 116 Indivior Pharmaceuticals shares in Q2 2026, an estimated $4.21K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4043 holding.
  • Farther Finance Advisors first reported a position in Indivior Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • Farther Finance Advisors's Indivior Pharmaceuticals position peaked at $38.7K in Q1 2024.
  • 49 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.